TrueMark Investments’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.4M Buy
38,039
+4,929
+15% +$1.36M 1.05% 30
2026
Q1
$9.78M Buy
33,110
+1,961
+6% +$582K 1.9% 14
2025
Q4
$8.51M Buy
31,149
+2,226
+8% +$605K 1.62% 21
2025
Q3
$7.81M Buy
28,923
+2,014
+7% +$548K 1.36% 24
2025
Q2
$7.42M Buy
26,909
+993
+4% +$270K 1.6% 11
2025
Q1
$6.88M Buy
+25,916
New +$6.39M 1.8% 8

Other funds holding CME

TrueMark Investments's CME Position: Q2 2026 in Review

TrueMark Investments increased its CME Group (CME) stake by 15% in Q2 2026, buying an estimated $1.36M and bringing the position to 38,039 shares worth $8.4M. The position accounts for 1.05% of the portfolio, ranked #30.

TrueMark Investments first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.78M in Q1 2026. 439 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • TrueMark Investments held 38,039 shares of CME Group worth $8.4M as of Q2 2026.
  • TrueMark Investments bought 4,929 CME Group shares in Q2 2026, an estimated $1.36M.
  • CME Group made up 1.05% of TrueMark Investments's portfolio in Q2 2026, its #30 holding.
  • TrueMark Investments first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • TrueMark Investments's CME Group position peaked at $9.78M in Q1 2026.
  • 439 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on TrueMark Investments's 13F filing for Q2 2026, filed 22 Jul 2026.